Page 94 - Read Online
P. 94

Squarzanti et al. J Cancer Metastasis Treat 2019;5:73  I  http://dx.doi.org/10.20517/2394-4722.2019.19                     Page 9 of 11

               Although several questions are still open, soon further improvements might help to generate
               microenvironments that also mimic the bacteria and virus migratory potential.


               CONCLUsION
               Overall this review highlights the importance of the in vitro 3D modeling research field for the study of
               microbial induced epithelial carcinogenesis. Yet, further improvements are still needed to reach the level of
               complexity of the real tissue. These models will hopefully help to better understand the respective roles of
               virus and bacteria in HR-HPV-related cancers.


               DeCLaRaTIONs
               Acknowledgments
               Authors thank Michelle Schoeman for the linguistic revision.


               Authors’ contributions
               Wrote part of the paper and prepared Table 1: Squarzanti DF
               Wrote part of the paper and prepared Figure 1: Sorrentino R
               Designed the review article and wrote part of the paper: Azzimonti B

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               DFS was partially supported by BioLab Srl/Probiotical SpA.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2019.


               ReFeReNCes
               1.   Human papillomavirus and related diseases report. HPV Information Center. Available from: https://hpvcentre.net/statistics/reports/XWX.
                   pdf?t=1571975032537 [Last accessed on 25 Oct 2019]
               2.   Pouyanfard S, Müller M. Human papillomavirus first and second generation vaccines-current status and future directions. Biol Chem
                   2017;398:871-89.
               3.   Takes RP, Wierzbicka M, D’Souza G, Jackowska J, Silver CE, et al. HPV vaccination to prevent oropharyngeal carcinoma: what can be
                   learned from anogenital vaccination programs? Oral Oncol 2015;51:1057-60.
               4.   Ferlay J, Ervik M, Lam F, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for
                   Research on Cancer. 2018. Available from: https://gco.iarc.fr/today [Last accessed on 25 Oct 2019]
               5.   Squarzanti DF, Sorrentino R, Landini MM, Chiesa A, Pinato S, et al. Human papillomavirus type 16 E6 and E7 oncoproteins interact with
                   the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
                   Virol J 2018;15:176.
               6.   Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patient-young, nonsmoker, nondrinker,
                   and HPV positive: evaluation. Otolaryngol Head Neck Surg 2014;151:375-80.
               7.   Sedghizadeh PP, Billington WD, Paxton D, Ebeed R, Mahabady S, et al. Is p16-positive oropharyngeal squamous cell carcinoma associated
   89   90   91   92   93   94   95   96   97   98   99